Global Cotinine Screening Devices Market Size study, By Device Type (Cassettes, Strips, Reader), By Sample Type (Blood Sample, Urine Sample, Saliva Sample), By End-User (Hospitals, Laboratories, Clinics, Workplace Screening Centers), and Regional Forecast

Global Cotinine Screening Devices Market Size study, By Device Type (Cassettes, Strips, Reader), By Sample Type (Blood Sample, Urine Sample, Saliva Sample), By End-User (Hospitals, Laboratories, Clinics, Workplace Screening Centers), and Regional Forecasts 2022-2028

Global Cotinine Screening Devices Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Cotinine Screening Devices refers to testing equipment utilized to measure the cotinine in human body. Cotinine is an alkaloid substance, formed in the human body after the consumption of nicotine. Cotinine is a biomarker indicating tobacco consumption. Cotinine is used for testing substance abuse in people as it stays in the human body for approximately 8 to 10 days. The growing prevalence of pulmonary disease and increasing number of smoking cessation campaigns as well as rising adoption of Cotinine Screening from corporates are factors that are accelerating the global market demand. For instance, according to World Health Organization (WHO) estimates – as of 2019, Chronic obstructive pulmonary disease (COPD) estimated as the third leading cause of death worldwide, causing 3.23 million deaths. Nearly 90% of COPD deaths in individuals under 70 years of age occurred in low- and middle-income countries (LMIC). Furthermore, the increasing adoption of nicotine testing from corporates would influence the growth of Cotinine Screening Devices. For instance, in January 2020, Arizona, USA based truck, trailer, and self-storage rental company U-Haul announced a nicotine-free hiring policy. This new policy would be effective in 21 states on February 1st , 2020. Also, growing incidence of lung cancer and surging healthcare infrastructure in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, low reimbursement rate for tobacco abuse testing impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Cotinine Screening Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing utilization of cotinine screening and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing adoption of nicotine screening and favorable government initiatives to curb smoking in the region, would create lucrative growth prospects for the global Cotinine Screening Devices Market across the Asia Pacific region.

Major market players included in this report are:
Abbott Laboratories
AlcoPro Inc.
Jant Pharmacal Corporation
Sinocare Inc., (PTS Diagnostics)
Mossman Associates
Nano-Ditech Corp
LifeSign LLC
ALFA Scientific
Ameritek USA.
Hangzhou Clongene Biotech Co.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device Type
Cassettes
Strips
Reader
By Sample Type
Blood Sample
Urine Sample
Saliva Sample
By End-User
Hospitals
Laboratories
Clinics
Workplace Screening Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Cotinine Screening Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Abbott Laboratories
AlcoPro Inc.
Jant Pharmacal Corporation
Sinocare Inc., (PTS Diagnostics)
Mossman Associates
Nano-Ditech Corp
LifeSign LLC
ALFA Scientific
Ameritek USA.
Hangzhou Clongene Biotech Co.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.